MET
MET
MetLife, Inc.
$90.06
+$2.86 (+3.28%)
Mkt Cap: $57.95B
Home / MET / News

Earnings Accelerate: New Frontier Strategy Drives MetLife Growth (MET Q1 2026 Earnings Call)

By Dr. Graph | Updated on May 26, 2026 | earnings

Export as clean Markdown. Drag & drop into ChatGPT, Claude, or Gemini.

MetLife delivered a strong start to the fiscal year, demonstrating robust earnings power and capital flexibility guided by its New Frontier strategic roadmap. The company achieved double-digit adjusted earnings expansion and broad-based premium growth across all key operating segments.

Diversified Portfolios and Underwriting Discipline Fuel Earnings Accretion

MetLife achieved adjusted earnings of $1.6 billion, demonstrating the substantial cash-generative power of its diversified business segments. Under the New Frontier roadmap, this bottom-line result translated into an adjusted return on equity that reached the very top of the company's target range. Additionally, disciplined capital management drove adjusted earnings per share to $2.42, representing a robust 23% year-over-year increase.

Expense Discipline and Targeted Tax Range Reconfirm Strong Long-Term Outlook

The executive team reaffirmed its confidence in the company's long-term financial commitments across cycles. Chief Financial Officer John McCallion projected the effective tax rate to range between 24% and 26% for the 2026 fiscal year. Furthermore, management expects continued operational efficiency to outperform the 12.1% direct expense ratio annual target. Michel Khalaf stated that the second year of the strategic roadmap is focused on acceleration and driving execution across market-leading businesses.

International Product Innovation and Group Benefits Expansion Drive Sales Volume

MetLife experienced broad-based demand across regional operations, supported by new product introductions. The Group Benefits segment recorded a 15% expansion in total sales, demonstrating strong relationships with employer clients. In Japan, sales grew substantially after the launch of a new accident and health offering, which surged 77% year-over-year. Robust economic factors and product innovation also lifted constant currency sales in Korea by 44% during the quarter.

Capital Optimization Actions and Resolution of Baseless Claims Highlight Analyst Q&A

Management addressed key balance sheet questions and disputed third-party financial claims during the analyst session. Michel Khalaf vigorously rejected a Canadian class-action indemnity claim of 200 million Canadian dollars, characterizing it as baseless and misleading. On the investment side, the company opportunistically completed a private equity secondary sale totaling $750 million to support third-party asset management growth. Additionally, strong fixed income demand led to a subordinated debt issuance that was oversubscribed by more than 5 times.

Disclaimer: This report is for informational purposes only and does not constitute financial or investment advice. Always conduct your own research or consult a qualified professional before investing. Past performance is not indicative of future results.

Frequently Asked Questions

What was MetLife's direct expense ratio in the first quarter of fiscal 2026?
The company achieved a direct expense ratio of 11.9% for the quarter, reflecting continued expense discipline and strong premium growth.
How much variable investment income did MetLife generate in the quarter?
MetLife generated pretax variable investment income of $518 million, driven by strong returns in its private equity portfolio.
What was the primary driver of top-line growth in MetLife's Retirement & Income Solutions segment?
The segment benefited from new sales of U.K. longevity and retail reinsurance additions, which contributed $1.5 billion of sales during the quarter.
What was MetLife's economic solvency position in its U.S. insurance operations?
The company reported a combined U.S. regulatory risk-based capital ratio of 379% for 2025, which comfortably exceeds its target of 360%.